Search

everythinglearnresearchcommunity

for

Search:↓

Using a call center to collect data in a trial for eye disease in diabetics led to high response rates and very little missing information.

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

The study concluded that Frontal fibrosing alopecia can affect younger people, is often missed in men, and may be autoimmune-related.

A new method helps diagnose alopecia areata using specific gene markers and could guide targeted treatments.

Computer vision techniques can help detect and assess skin conditions like vitiligo, alopecia areata, and dermatitis.

A new method can quickly and accurately detect drugs in hair.

KLB and EIF3C genes are key for early diagnosis of vitiligo and alopecia areata.

Checking family social conditions in tourniquet syndrome cases can help find neglect.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

A chemical called 5-Bromo-2′-deoxyuridine caused rapid hair loss in mice by killing certain skin cells through a specific cell death pathway.

Method measures tamsulosin and finasteride in medicine accurately.

The revised Chinese Symptom Checklist-90 is more reliable and valid for psychological assessments.

Catalase in processed meats may emit electromagnetic fields that increase cancer risk.

New method effectively detects illegal hormones in anti-aging foods.

Computer-aided imaging system helps measure balding area in female pattern hair loss.

A Turkish family with sparse hair and eyebrow loss has a mutation in the U2HR gene linked to Marie Unna hereditary hypotrichosis.

The model accurately predicts hair loss by analyzing various factors.

Genetic testing is crucial for diagnosing rare hair loss disorders.

Disease-specific tools better assess alopecia areata's impact on quality of life.

The model predicts minoxidil's effectiveness and side effects better than traditional methods.

High-dose UVA-1 therapy improves symptoms and skin condition in sclerosing skin disease.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

The method for measuring uncertainty in finasteride tablets is reliable.

A new method accurately detects illegal JAK inhibitors in hair loss cosmetics.

A new automated method accurately measures hair damage using microscopic images.

Parental uveitis increases offspring's risk and severity of autoimmune eye disease.